{"id":"W4390061629","doi":"10.1182/bloodadvances.2023011814","title":"Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Gateway for Cancer Research; CSL Behring; Bristol-Myers Squibb; Amgen; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Medicine; Hematopoietic cell; Internal medicine; Cyclophosphamide; Transplantation; Haematopoiesis; Stem cell; Chemotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008047121,0.0001027811,0.0001384452,0.0003510833,0.0002766781,0.0005360398,0.000320816,0.0002246898,0.006851382],"category_scores_gemma":[0.002075977,0.00006928933,0.0002752476,0.0004499309,0.0001882182,0.0004967717,0.000588815,0.0004727316,0.0004317295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001891108,"about_ca_system_score_gemma":0.00039113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001024692,"about_ca_topic_score_gemma":0.001739293,"domain_scores_codex":[0.9995701,0.0001300833,0.00004736345,0.00008523568,0.00009820554,0.0000690766],"domain_scores_gemma":[0.9984723,0.000405575,0.0008357896,0.00008920685,0.000048848,0.0001482906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001209401,0.00006082908,0.9850306,0.00002552874,0.00004510034,0.0002788643,0.00006434765,0.0008955557,0.000367645,0.0002889345,0.0005316555,0.01229],"study_design_scores_gemma":[0.00004405723,0.0003223061,0.9764091,0.0001043411,0.0001536658,0.005290908,0.0008401385,0.009377782,0.001254126,0.001857035,0.004331173,0.00001541598],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978408,0.000247587,0.0005150278,0.0001485345,0.000006404046,0.000009441073,0.0003427881,0.000009003822,0.000880503],"genre_scores_gemma":[0.9993145,0.00006065137,0.0002043397,0.00004515346,0.000005708762,0.00000412449,0.00021575,0.000001567405,0.0001481622],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006851382,"threshold_uncertainty_score":0.02292013,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02645697796824841,"score_gpt":0.306195066447848,"score_spread":0.2797380884795996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}